IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
559 days ago
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
825 days ago
TSX Ends More Than 1% Up
After a weak start and a subsequent recovery, the Canadian market slipped into negative territory around early afternoon on Friday, but gained in strength after that with stocks from industrials, financials, utilities and consumer staples attracting buyers.
RTTNews
|
2 days ago
Dollar Rises Against Major Counterparts
The U.S. dollar climbed higher on Friday, extending gains from the previous session following U.S. President Donald Trump's announcement that the 25% tariffs on Canada and Mexico, and an additional 10% on China, will take effect early next week.
RTTNews
|
2 days ago
German Inflation Steady At 2.3% In February
Consumer price inflation in Germany was unchanged in February, while the core price growth slowed as the cost of food increased strongly, preliminary data from the statistical office Destatis showed on Friday.
RTTNews
|
2 days ago
Canadian Market Modestly Higher In Cautious Trade
The Canadian benchmark S&P/TSX Composite Index is modestly higher in late afternoon trades on Friday with stocks turning in a mixed performance.
Worries about U.S. tariffs and their potential impact on global economic growth appear to be weighing on sentiment. Investors are also digesting the nation's GDP report and U.S. PCE reading.
RTTNews
|
2 days ago
Pound Retreats Amid Risk Aversion
The pound pulled back against its most major counterparts in the New York session on Friday, as risk sentiment dampened after a meeting between President Donald Trump and Ukrainian President Volodymyr Zelenskyy devolved into a shouting match.
RTTNews
|
2 days ago
Swiss Market Ends On Firm Note
After a weak start and a subsequent recovery, the Swiss market struggled for direction till mid afternoon on Friday, but gained in strength thanks to some brisk buying at several counters in last ninety minutes of the day's session.
RTTNews
|
2 days ago
